Cryo-EM Revolutionizing Structure-Based Drug Design

What Is Cryo-EM in Drug Discovery?

Cryo-electron microscopy (cryo-EM) is a structural biology technique that determines three-dimensional structures of biomolecules by flash-freezing samples in vitreous ice and imaging them with an electron microscope. In drug discovery, cryo-EM has revolutionized structure-based drug design (SBDD) by enabling structural determination of membrane proteins, large protein complexes, and flexible targets that were previously intractable.

The "cryo-EM resolution revolution," enabled by direct electron detectors and advanced image processing algorithms, earned Jacques Dubochet, Joachim Frank, and Richard Henderson the 2017 Nobel Prize in Chemistry. Since then, cryo-EM has become an essential tool in pharmaceutical research, particularly for GPCRs, ion channels, and other membrane protein drug targets.

Data: Cryo-EM Impact on Drug Discovery

How: Cryo-EM Workflow for Drug Discovery

Step 1: Sample Preparation

1. Express and purify target protein (often membrane protein)
2. Complex with drug candidate or known ligand
3. Apply sample to cryo-EM grid (3 μL, 0.1-5 mg/mL)
4. Vitrify by plunge-freezing in liquid ethane (-180°C)
5. Screen grids for ice thickness and particle distribution

Step 2: Data Collection

1. Load grid into electron microscope (200-300 kV)
2. Collect movies (50-60 frames per movie) at low dose (~50 e⁻/Ų)
3. Automated data collection (EPU, SerialEM): 1,000-10,000 movies
4. Typical collection time: 2-5 days per dataset

Step 3: Image Processing

1. Motion correction (MotionCor2)
2. Contrast transfer function estimation (CTFFIND)
3. Particle picking (cryoSPARC, RELION)
4. 2D classification (remove bad particles)
5. 3D classification (separate conformational states)
6. 3D refinement (ab initio + homogeneous/heterogeneous)
7. Map sharpening and local resolution estimation

Step 4: Model Building and Drug Design

1. Build atomic model into cryo-EM map (COOT, phenix.real_space_refine)
2. Identify ligand binding pose and key interactions
3. Analyze water networks and allosteric sites
4. Design improved ligands based on structural insights
5. Iterate: synthesize → bioassay → new cryo-EM structure

Step 5: Integration with Computational Methods

1. Use cryo-EM structures as input for docking and FEP
2. Perform MD simulations starting from cryo-EM conformations
3. Validate computational predictions against experimental structures

Comparison: Cryo-EM vs. X-ray Crystallography vs. AlphaFold

Summary: Key Takeaways

1. Cryo-EM has transformed SBDD by enabling structures of membrane proteins and dynamic complexes.
2. Resolution now rivals X-ray crystallography for many targets, with the advantage of not requiring crystallization.
3. Heterogeneous classification reveals multiple conformational states, informing allosteric drug design.
4. Cryo-EM is particularly impactful for GPCRs, ion channels, and other membrane protein drug targets.
5. Integration with computational methods (docking, MD, FEP) maximizes the value of cryo-EM structures.

References

1. Henderson, R. "The potential and limitations of neutrons, electrons and X-rays for atomic resolution protein structure determination." Quarterly Reviews of Biophysics (2017).
2. Merino, F. & Raunser, S. "The future of cryo-EM in drug discovery." Nature Reviews Drug Discovery (2024).
3. Subramaniam, S. et al. "Cryo-EM visualization of drug-target interactions." Cell (2023).
4. Cheng, Y. "Single-particle cryo-EM—How did it get here and where will it go?" Science 361, 876-880 (2018).
5. Renaud, J.P. et al. "Cryo-EM in drug discovery: achievements, limitations and prospects." Nature Reviews Drug Discovery 17, 471-492 (2018).